Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act - PubMed

Affiliations

• PMID: 18174196
• DOI: 10.1093/jac/dkm499

Review

Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act

Robert W Burgoyne et al. J Antimicrob Chemother. 2008 Mar.

Abstract

Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles' heels of HAART. This article reviews research findings on treatment and QOL outcomes a decade into the HAART era.

Similar articles

• Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.

  Venkat A, Piontkowsky DM, Cooney RR, Srivastava AK, Suares GA, Heidelberger CP. Venkat A, et al. Ann Emerg Med. 2008 Sep;52(3):274-85. doi: 10.1016/j.annemergmed.2008.01.324. Epub 2008 Mar 21. Ann Emerg Med. 2008. PMID: 18358567 Review.

• Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan.

  Yen CF, Tsai JJ, Lu PL, Chen YH, Chen TC, Chen PP, Chen TP. Yen CF, et al. Psychiatry Clin Neurosci. 2004 Oct;58(5):501-6. doi: 10.1111/j.1440-1819.2004.01292.x. Psychiatry Clin Neurosci. 2004. PMID: 15482581

• [An updated overview of HAART in HIV-infected adults].

  Imamura A. Imamura A. Nihon Rinsho. 2010 Mar;68(3):460-4. Nihon Rinsho. 2010. PMID: 20229791 Review. Japanese.

• Impact of depression on HIV outcomes in the HAART era.

  Hartzell JD, Janke IE, Weintrob AC. Hartzell JD, et al. J Antimicrob Chemother. 2008 Aug;62(2):246-55. doi: 10.1093/jac/dkn193. Epub 2008 May 2. J Antimicrob Chemother. 2008. PMID: 18456650 Review.

• Critical care of HIV infected patients in the highly active antiretroviral therapy era.

  Corona A, Raimondi F. Corona A, et al. Minerva Anestesiol. 2007 Dec;73(12):635-45. Minerva Anestesiol. 2007. PMID: 18046294 Review.

Cited by

• Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen.

  Colombo GL, Di Matteo S, Maggiolo F. Colombo GL, et al. Clinicoecon Outcomes Res. 2013;5:59-68. doi: 10.2147/CEOR.S38977. Epub 2013 Feb 12. Clinicoecon Outcomes Res. 2013. PMID: 23430273 Free PMC article.

• Host-pathogen interactions of retroviruses.

  Waheed AA, Brass AL, Gummuluru S, Tachedjian G. Waheed AA, et al. Mol Biol Int. 2012;2012:648512. doi: 10.1155/2012/648512. Epub 2012 Oct 24. Mol Biol Int. 2012. PMID: 23150826 Free PMC article. No abstract available.

• Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes.

  Ande A, McArthur C, Kumar A, Kumar S. Ande A, et al. Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1453-64. doi: 10.1517/17425255.2013.816285. Epub 2013 Jul 4. Expert Opin Drug Metab Toxicol. 2013. PMID: 23822755 Free PMC article. Review.

• Factors related to quality of life in treatment-adherent, successfully treated HIV patients in France.

  Côté J, Delmas P, Delpierre C, Sylvain H, Delon S, Rouleau G. Côté J, et al. Open Nurs J. 2009 Apr 30;3:10-7. doi: 10.2174/1874434600903010010. Open Nurs J. 2009. PMID: 19543547 Free PMC article.

• Health-related quality of life among military HIV patients on antiretroviral therapy.

  Emuren L, Welles S, Evans AA, Polansky M, Okulicz JF, Macalino G, Agan BK; Infectious Disease Clinical Research Program HIV Working Group. Emuren L, et al. PLoS One. 2017 Jun 7;12(6):e0178953. doi: 10.1371/journal.pone.0178953. eCollection 2017. PLoS One. 2017. PMID: 28591161 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information